MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-33-0196260
Socomed Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹113.64 Cr
▼ 20% YoY
Net profit · FY 2025
₹19.24 Cr
Net margin 16.9%
EBITDA · FY 2025
₹29.09 Cr
EBITDA margin 25.6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹48.62 Lakh
Issued & subscribed
Open charges
₹2.53 Cr
Secured borrowings
Company age
18 yrs
Est. 2008
Employees · EPFO
30
Provident fund records
About Socomed Pharma Private Limited
Data last updated:
Socomed Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2008PTC181516. Its GSTIN is 27AALCS9047D1Z2 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹48.62 Lakh. It is led by directors Aasif Amirkhan Dange and Bakhtawar Mairaj Aasif Dange.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹113.64 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹19.24 Cr (net margin 16.9%) and EBITDA of ₹29.09 Cr (EBITDA margin 25.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over five years.
The company has about 30 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Socomed Pharma. As per MCA filings, the company has open charges of ₹2.53 Cr on record. Court records list 58 cases involving the company, including 54 filed by the company and 4 filed against it; 12 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 rights issue); the latest was in March 2022. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Pharose Remedies Limited with revenue of ₹115.39 Cr. The company has 16 MSME Form 1 returns on record between 2019 and 2024, listing 6,907 overdue payments to 54 micro and small suppliers.
Socomed Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0196260). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website socomedpharma.com.
Company details
CIN U24233MH2008PTC181516
Registration Number 181516
Incorporation Date 24 April 2008
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-33-0196260
Recognitions & Rankings of Socomed Pharma
Contact details
Socomed Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is socomedpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOrm B – Wing Unit No 112 Upper Gr. Survey No. 169 Aarey Milk Colony Near Unit No. 26 Gor, Egaon (E), Mumbai, Maharashtra, India – 400065
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Socomed Pharma Private Limited, buy the company report.
Comprehensive company report
Socomed Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Socomed Pharma operates one associated brand: Socomed Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of affordable generic medicines in various dosage forms is conducted by Socomed Pharma. | socomedpharma.com |
Business activity
The main business activity of Socomed Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Socomed Pharma Private Limited, buy the company report.
Financials of Socomed Pharma Private Limited
FY 2025 filings availableSocomed Pharma Private Limited reported revenue of ₹113.64 Cr (down 20% YoY) for FY 2025.
Revenue · FY 2025
₹113.64 Cr ▼ 20%
Net profit · FY 2025
₹19.24 Cr margin 16.9%
EBITDA · FY 2025
₹29.09 Cr margin 25.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 20%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 15%
5 years · compounded
▲ 15%
Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.6% | ||||
| Net Profit Margin | 16.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Socomed Pharma Private Limited, buy the company report.
Board of directors of Socomed Pharma Private Limited
Socomed Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aasif Amirkhan Dange Also directs: Kind Health and Hygiene Private Limited | Director | 13 Dec 2011 | 14 Years 10 Months | Current |
| Bakhtawar Mairaj Aasif Dange | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Socomed Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharose Remedies Limited | ₹115.39 Cr (FY 2025) | 4.0% | Punjab, India | |||
| Biogenetic Drugs Private Limited | ₹115.34 Cr (FY 2025) | -2.0% | Jaipur, Rajasthan, India | |||
| Synthokem Labs Private Limited | ₹113.98 Cr (FY 2024) | 2.0% | Patancheru, Telangana, India | |||
| Savorite Pharmaceuticals Private Limited | ₹113.71 Cr (FY 2025) | -12.0% | Vadodara, Gujarat, India | |||
| Socomed Pharma Private Limitedthis company | ₹113.64 Cr (FY 2025) | ₹19.24 Cr | 16.9% | -20.0% | 30 | Mumbai, Maharashtra, India |
| Seagull Pharmaceuticals Pvt Ltd | ₹113.36 Cr (FY 2025) | 8.0% | Naraina Vihar, Delhi, India | |||
| Stadmed Pvt Ltd | ₹112.88 Cr (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Shree Ganesh Remedies Limited | ₹112.33 Cr (FY 2025) | -13.0% | Anklesvar, Gujarat, India | |||
| Unicure Remedies Private Limited | ₹112.25 Cr (FY 2025) | -13.0% | Vadodara, Gujarat, India | |||
| Apple Formulations Private Limited. | ₹111.56 Cr (FY 2025) | 3.0% | Delhi, India |
To see the full peer comparison of Socomed Pharma Private Limited, buy the company report.
Auditor
Socomed Pharma Private Limited is audited by M/s. Y. K. Desai & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s. Y. K. Desai & Co. | FY 2024 | 102370W |
Shareholding
The shareholding of Socomed Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Socomed Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.53 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Apr 2019 | 100267108 | Standard Chartered Bank | ₹2.53 Cr | Open |
To see the full charge records of Socomed Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Socomed Pharma Private Limited has 4 deals on record (3 secondary share transfers, 1 rights issue); the latest was in March 2022.
Total deals
4
Secondary share transfers
3
Rights issue
1
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2013 | Rights issue | ₹7.4 Lakh | Investors: 3 individuals |
| Dec 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Socomed Pharma Private Limited has 58 court cases on record: 54 filed by Socomed Pharma, 4 filed against it. 12 cases are pending and 46 are disposed.
Total cases
58
Filed by the company
54
Filed against the company
4
Pending
12
Disposed
46
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 57 | 3 | 12 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 58)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Balaxi Overseas Private Limited and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed by the company against Biotime Pharmaceuticals Private Limited | Pending |
| High Court | Court case (COMIP) | Filed by the company against Agonist Pharmaceuticals Pvt. Ltd | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against Agonist Pharmaceuticals Pvt. Ltd | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed by the company against Agonist Pharmaceuticals Pvt. Ltd | Pending |
To see the full case history of Socomed Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Socomed Pharma Private Limited was last rated by Crisil on 10 Sep 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 10 Sep 2021 |
To see the full credit ratings and regulatory alerts of Socomed Pharma Private Limited, buy the company report.
MSME payment delays
Socomed Pharma Private Limited has 16 MSME Form 1 returns on record between 2019 and 2024, listing 6,907 overdue payments to 54 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 54)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Wincoat Colours and Coatings Private Limited | |||
| M/S Shako Plastick | |||
| an individual supplier | |||
| Jasmine Art Printers Private Limited | |||
| M/S Sai Shraddha Packaging |
To see the full MSME payment records of Socomed Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Socomed Pharma has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Kind Health and Hygiene Private Limited | U21001PN2013PTC149527 |
To see the full group structure of Socomed Pharma Private Limited, buy the company report.
Employees & EPFO
Socomed Pharma Private Limited has a workforce of 30 employees on its EPFO records as of Oct 11, 2025, across 1 active EPFO establishment.
Employee count
30
Active EPFO establishments
1
Employee growth
7.14%
GST
Socomed Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCS9047D1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Socomed Pharma Private Limited, buy the company report.
Recent activity
Socomed Pharma Private Limited has 5 board changes on record since 2011: 2 appointments and 3 cessations. The latest: Bakhtawar Mairaj Aasif Dange ceased to be Additional Director on 30 Nov 2021.
AGM
Socomed Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Socomed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Standard Chartered Bank of Rs. 253.00 Lakh registered on 22 Apr 2019 with Charge ID 100267108 was modified on 22 Nov 2023.
Ceased
Bakhtawar Mairaj Aasif Dange ceased to be Additional Director.
Ceased
Syed Jahan Shaukat ceased to be Director.
Appointed
Bakhtawar Mairaj Aasif Dange was appointed as Director.
Charges
A charge with Standard Chartered Bank amounted to Rs. 253.00 Lakh with Charge ID 100267108 was registered on 22 Apr 2019.
Ceased
Lata Shreedhar Tiwari ceased to be Director.
Appointed
Aasif Amirkhan Dange was appointed as Director.
Incorporation
24 Apr 2008
Socomed Pharma Private Limited was registered on 24 Apr 2008 with Roc Mumbai & aged 18 years 6 months as per MCA records.
Frequently asked questions
Socomed Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2008 (18+ years old) and is registered under CIN U24233MH2008PTC181516.
Socomed Pharma has 2 current directors:
- Aasif Amirkhan Dange - Director
- Bakhtawar Mairaj Aasif Dange - Director
The latest financial statements of Socomed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Socomed Pharma is 27AALCS9047D1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Socomed Pharma is U24233MH2008PTC181516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Socomed Pharma has 58 court cases on record: 54 filed by the company and 4 filed against it. 12 are pending. Most are in the high courts.
Socomed Pharma was incorporated on 24 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
Socomed Pharma has 4 deals on record (3 secondary share transfers, 1 rights issue); the latest was in March 2022.
The peers of Socomed Pharma by revenue are Pharose Remedies Limited, Biogenetic Drugs Private Limited, Synthokem Labs Private Limited, Savorite Pharmaceuticals Private Limited, Seagull Pharmaceuticals Pvt Ltd and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bakhtawar Mairaj Aasif Dange ceased to be Additional Director on 30 Nov 2021. Syed Jahan Shaukat ceased to be Director on 31 Oct 2021. Bakhtawar Mairaj Aasif Dange was appointed as Director on 01 Oct 2021. Socomed Pharma has 5 board changes on record in total.
Yes, Socomed Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-33-0196260).
Socomed Pharma has 16 MSME Form 1 returns on record between 2019 and 2024, listing 6,907 overdue payments to 54 micro and small suppliers. The latest return was filed on 19 Jun 2024.